Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03088579 : Intraoperative Brachytherapy for Central Nervous System Lesions: A Validation Study of a Radioactive Seed Loading Device
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Planned for resection of aggressive primary or metastatic brain tumor and appropriate
for adjuvant radiotherapy.

- Zubrod Performance Score of 0-2.

- 18 years of age or older.

- Pre-operative stereotactic CT or MRI.

- Life expectancy >26 weeks.

- History and physical for all patients and detailed neurological exams.

- Signed study-specific informed consent form prior to study entry.

Exclusion Criteria:

- Negative biopsy if presumed diagnosis on imaging.

- External beam therapy is allowed if the implant is being used instead of a boost or
cone down treatment.

- Life expectancy < 26 weeks.

- Inability to undergo post-operative CT for implant assessment, or postoperative
follow-up imaging.

- Major medical or psychiatric illness, which, in the investigator's opinion, would
prevent completion of treatment and/or interfere with follow-up.

- Inability or refusal to provide informed consent.

- Prior radiation therapy in excess of 100Gy to site of implant.

- Patients in which there is no cranium in place (for example, bone flap removed for
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557